Tagged Articles

Testim 98 articles

Endo agrees to settle 400+ testosterone side effects lawsuits

Endo International has reached a “master settlement agreement” to resolve “all known” cases accusing the company of overstating the benefits of its testosterone replacement therapy and failing to warn men that use of the drug increases the risk for heart attacks, strokes and blood clots. Endo faces about 1,300 testosterone lawsuits, about 900 of which are pending in a federal multidistrict litigation in the Northern District of Illinois against Endo and several other testosterone manufacturers. Other testosterone cases are pending in the Philadelphia County Court of Common Pleas and other states. In February, Endo announced a tentative settlement agreement and ... Read More

Auxilium settles testosterone side effects case before trial

Days before Auxilium Pharmaceuticals Inc., was scheduled to go to court over claims that its testosterone replacement therapy Testim caused an Alabama man to suffer a stroke, the drug company announced it had settled with the plaintiff, the terms of which have not been disclosed. The lawsuit was brought by Robert Hoehl and his wife Kathleen, and the trial was scheduled to begin Jan. 8. At one point, the case was positioned as the lead in a proposed mass tort over testosterone side effects. Hoehl sued Auxilium in 2014 alleging that in October 2011, at the age of 62, he ... Read More

Endo faces more testosterone side effects trials

Endo Pharmaceutical may have gotten a pass on the latest testosterone side effects trial, but its problems are far from resolved. The drug company faces nearly 1,300 lawsuits involving its testosterone replacement therapy Testim, as well as other testosterone products it markets, in state and federal courts. Endo faced the third trial in a class action lawsuit against several manufacturers of testosterone treatments over claims that the drugs caused cardiovascular side effects including heart attacks, strokes, blood clots and death. The first two trials were waged against AbbVie Inc., maker of the blockbuster testosterone treatment AndroGel, and resulted in verdicts ... Read More

Testim testosterone side effects trial scheduled for January

Philadelphia County Court of Common Pleas Judge Mary Colins denied Auxilium Pharmaceuticals Inc.’s request to worm out of an upcoming trial over alleged testosterone side effects linked to its hormone replacement drug Testim. Auxilium had cited federal preemption as a grounds for summary judgment. The trial involves the case of Alabama resident Robert Hoehl and his wife Kathleen. Hoehl sued Auxilium in 2014 alleging that in October 2011, at the age of 62, he was prescribed Testim to treat fatigue and erectile dysfunction related to low testosterone. But in July 2012, Hoehl suffered a stroke, which he believes was caused ... Read More

Auxilium escapes verdict in testosterone side effects trial

Auxilium Pharmaceuticals Inc., maker of the testosterone replacement therapy Testim, escaped a verdict in the first bellwether trial blaming Testim for a man’s heart attack. This marks the first victory in multidistrict litigation (MDL) over testosterone side effects that names several testosterone manufacturers. The first two bellwether trials were against AbbVie Inc., makers of AndroGel, and resulted in combined $290 million in verdicts. The seven-day trial focused on the case of Steve Holtsclaw, who claimed he was prescribed Testim after complaining to his doctor about chronic fatigue. Months after treatment, Holtsclaw suffered a heart attack. He since learned that studies ... Read More

Testim benefits not worth the heart attack, patient says

Steve Holtsclaw’s heart attack in 2014 weighs on his mind daily. He’s more emotional now, and constantly wonders, “How much longer have I got?” the 62-year-old man told an Illinois federal jury during the first bellwether trial in a multidistrict litigation (MDL) involving cardiovascular risks with Auxilium Pharmaceuticals Inc.’s testosterone replacement therapy Testim. Holtsclaw was prescribed Testim in 2013 after complaining to his doctor about chronic fatigue. A blood test showed his testosterone levels were low. Months later, Holtsclaw suffered a heart attack. He received two stents and was put on several medications to help prevent a second heart attack. ... Read More

Opening arguments begin in latest testosterone trial

The Food and Drug Administration (FDA) repeatedly rejected Auxilium Pharmaceuticals Inc.’s requests to expand the indication of its testosterone replacement therapy Testim to include age-related drops in testosterone, yet the drug company continued to market its product for age-related symptoms, attorneys for Steve Holtsclaw said during opening arguments. As a result, Holtsclaw trusted the product was safe, but realized the error of his ways when he suffered a heart attack seven months after starting the hormone therapy. Holtsclaw’s lawsuit is the first bellwether to reach trial against Auxilium in a multidistrict litigation that names numerous manufacturers of testosterone treatments. Two ... Read More

Auxilium to take hot seat in latest testosterone side effects trial

Weeks after two juries handed down multi-million verdicts to two men who claimed that AbbVie Inc., did not adequately warn of cardiovascular risks with its testosterone replacement therapy AndroGel, drug maker Auxilium Pharmaceuticals LLC will take the hot seat in court over allegations that its testosterone treatment Testim caused a man to suffer a heart attack. Steve Holtsclaw is one of thousands of men alleging manufacturers of testosterone replacement therapy misrepresented what their products were safe and effective to treat while failing to warn that the drugs increased the risk of heart attacks, strokes and blood clots. Holtsclaw claimed he ... Read More

AbbVie asks judge to toss bellwether case in testosterone side effects MDL

Drug maker AbbVie Inc. asked a federal judge to toss a lawsuit alleging the company’s testosterone replacement therapy AndroGel causes injuries, arguing the plaintiff withheld information about his condition until after the discovery process was completed. AbbVie told U.S. District Judge Matthew Kennelly in Chicago that Froylan Garcia’s claim was no longer valid because his attorney did not find an expert witness to back up his claims that AndroGel caused him to develop a blood clot in 2013. Garcia’s case was one of eight selected by Judge Kennelly to serve as bellwether trials in a multidistrict litigation (MDL) of more than 5,500 ... Read More

Canadian health officials offer new guidelines for diagnosing, treating Low T

Canadian health officials have issued new guidelines designed to help doctors and patients with the diagnosis and treatment of low testosterone, and to curb over-prescribing in particular to men whose testosterone levels were never checked for low levels of the hormone. The guidelines, published in the Canadian Medical Association Journal, were created by a task force a year after Health Canada warned that testosterone replacement therapy may lead to “serious and possible life-threatening health and blood vessel problems such as heart attack, stroke,” blood clots and irregular heart rhythm. Health Canada has also warned that research suggests that men with ... Read More